University of Illinois Chicago
Chicago, Illinois, 60607, United States
Location status: Recruiting
NCT Number: NCT07428278
The aims of this study are to (1) assess the feasibility, acceptability, and usability of the ROCKS intervention among patients with advanced cancer and their family caregivers through a randomized controlled trial in a cancer center setting; (2) evaluate the preliminary efficacy of ROCKS, as compared to usual care, on changes in completion of advance directives; and (3) explore the dyadic effects of resilience on self-efficacy, optimism, dyadic communication and coping, anxiety, and depression using an actor-partner interdependence model.
Interested in participating?
Request Info18 year–80 year
All sexes
Interventional
Not applicable
Chicago, Illinois, 60607, United States
Location status: Recruiting
Patients with advanced cancer have not fully benefited from advance care planning due to the high levels of anxiety and depression experienced and other barriers that affect their appraisals and coping. Despite the protective effects of resilience, there have been few clinical trials improving the resilience skills of patients with advanced cancer and their family caregivers to help initiate advance care planning discussions and sustain engagement. This research evaluates the impact of a web-based resilience-building intervention called ROCKS on enhancing the completion of advance directives, as well as improving resilience, coping, anxiety, and depression among patients with advanced cancer and their family caregivers.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The intervention will be provided to participants to strengthen optimism, communication skills, knowledge, and self-efficacy to support patients and family caregivers in engaging in advance care planning discussions.
An advance directive called Five Wishes will be provided to participants to increase their knowledge about advance care planning.
Time frame: Week 8
Completion of Five Wishes
Time frame: Week 8
Assessed using the Connor-Davidson Resilience Scale (Range: 0-100; higher scores indicate a greater level of resilience)
Time frame: Week 8
Assessed using the Revised Compound PsyCap Scale (Range: 3-18; higher scores indicate a greater level of optimism)
Time frame: Week 8
Assessed using the Dyadic Coping Inventory (Range: 35-175; higher scores indicate greater perceived communication and dyadic coping)
Time frame: Week 8
Assessed using the Advance Care Planning Engagement Survey (Range: 2-10; Higher scores indicate a greater knowledge of advance care planning)
Time frame: Week 8
Assessed using the Advance Care Planning Engagement Survey (Range: 12-50; Higher scores indicate greater self-efficacy in advance care planning)
Time frame: Week 8
Assessed using the Generalized Anxiety Disorder-7 (Range: 0-21; Higher scores indicate higher levels of anxiety)
Time frame: Week 8
Assessed using the Patient Health Questionnaire-9 (Range: 0-27; Higher scores indicate higher levels of depression)
Contact information is provided by the study sponsor or research team.
University of Illinois at Chicago
Other
Facilitating Advance Care Planning Discussions Between Patients With Advanced Cancer and Their Family Caregivers Using a Resilience-Building Intervention: A Randomized Controlled Trial.
Acronym: ROCKS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07147023
Advanced Cancer, Cancer
Boston, Massachusetts, United States
View Trial DetailsNCT02966509
Advanced Cancer, Astrocytoma
View Trial DetailsNCT06420609
Advanced Cancer, Death
Sant Cugat del Vallès, Barcelona, Spain
View Trial DetailsNCT01901237
Advanced Cancer, Behavior
Halifax, Nova Scotia, Canada
View Trial Details